Skip to main content
Nucleus logoLink to Nucleus
. 2013 Sep 30;4(5):374–378. doi: 10.4161/nucl.26654

The SWI/SNF tumor suppressor complex

Regulation of promoter nucleosomes and beyond

Ping Lu 1,2,3, Charles WM Roberts 1,2,3,*
PMCID: PMC3899127  PMID: 24145903

Abstract

Nucleosomes, octamers of histones wrapped in 147 bp of DNA, are the basic unit of chromatin. In eukaryotic cells, the placement of nucleosomes along the genome is highly organized, and modulation of this ordered arrangement contributes to regulation of gene expression. The SWI/SNF complex utilizes the energy of ATP hydrolysis to mobilize nucleosomes and remodel chromatin structure. Recently, the complex has also been implicated in oncogenesis as genes encoding multiple SWI/SNF subunits have been found mutated at high frequency across a wide spectrum of cancers. Given that epigenetic aberrations are now characterized as a hallmark of human cancer, hypotheses have been put forth that the SWI/SNF complex inhibits tumor formation by regulating key chromatin functions. To understand how the SWI/SNF complex contributes to nucleosome organization in vivo we performed a genome-wide study in mammalian cells. We found that inactivation of SWI/SNF subunits leads to disruptions of specific nucleosome patterning and a loss of nucleosome occupancy at a large number of promoters. These findings define a direct relationship between the SWI/SNF complex, chromatin structure, and transcriptional regulation. In this extra view, we discuss our findings, their relevance to gene regulation, and possible links to the tumor suppression activities of the SWI/SNF complex.

Keywords: nucleosome, chromatin remodeling, epigenetic instability, SWI/SNF, SNF5, BAF47, SMARCB1, Brg1, SMARCA4

Introduction

Eukaryotic cells compact their genetic material into chromatin ultimately achieving orderly, and dynamic, packaging of nearly two meters of DNA into a nucleus only a few microns in diameter.1 At the initial level of chromatin formation, while nucleosomes are found broadly throughout the genome, their placement is not random.2 Rather, stereotypical patterns occur, particularly at gene promoters and at other regulatory loci.3 Establishment of nucleosomal occupancy at these regions is in part contributed to by DNA sequence.2,3 However, ATP remodelers also serve an important role in this process. For example, the addition of crude yeast extract to purified histones and genomic DNA results in the reconstitution of nucleosome arrays in vitro.4 However, the addition of ATP results in generation of array positions that are a closer match for those found in vivo. Such results suggest that ATP-consuming chromatin remodelers are involved in the establishment, and also dynamic regulation, of nucleosome arrays and that they can override preferred nucleosome positions dictated by the underlying DNA sequence.

The transcriptional start sites of most active genes in metazoans are located in a nucleosome-depleted region (NDR) flanked by two specifically-positioned nucleosomes known as the -1 and +1 nucleosomes.2 Downstream, this structure is followed by a spaced array of nucleosomes leading into the gene body. In the promoter region, cis-regulatory elements are highly concentrated, and can be targeted by various transcriptional regulators for transcriptional activation and initiation. However, the embedding of promoter DNA into the nucleosome structure restricts the accessibility of the DNA to transcription factors and is therefore inhibitory to transcription.5 In this regard, only genes that are actively repressed have nucleosome-covered promoters.2 Most other genes adapt an open chromatin configuration, which is thought to leave the genes ready for transcription factor binding and for launching swift transcriptional response.5 It is within this chromatin environment that dynamic modulation of nucleosome placement is thought to make important contributions to the control of gene expression. However, the mechanisms by which this is achieved, the effects of nucleosome landscape on transcription, and the contributions of individual remodeling complexes are poorly understood.

ATP-dependent chromatin remodelers are large multimeric machines that utilize the energy derived from ATP hydrolysis to unwrap, mobilize, reconstruct or eject nucleosomes and alter chromatin structure.6 Based on the domain structures of the ATPase subunits, chromatin remodelers are divided into five families: the SWI/SNF, ISWI, CHD, INO80 and SWR1 complexes.6 Of these, the SWI/SNF complex is perhaps the most studied remodeler. This family of complexes was initially identified in yeast via genetic screenings searching for genes that regulate mating type switching (SWI) and sucrose fermentation (Sucrose Non-Fermenting, SNF).6 Because of evolutionary differences in the composition of the complex between yeast and mammals, the mammalian SWI/SNF complex has also been referred to as mSWI/SNF or the BAF (BRG1 Associated Factors) complex. Each mammalian SWI/SNF complex consists of roughly 10–14 subunits and has a molecular mass of approximately 2 MDa. In vitro, the complex is able to break DNA-histone interactions, slide histone core octamers on DNA and dissociate the histone core from DNA.7-9 In evaluating functional contributions of these complexes, genetic studies have suggested that SWI/SNF complex members are important for controlling cell fate, lineage specification, and cell proliferation in vivo, likely by acting as a master transcriptional regulators.10,11

The SWI/SNF complex has also emerged as a critical tumor suppressor.6 The first clue to a role for the complex in tumor suppression came when the SNF5 (SMARCB1/INI1/BAF47) core subunit was found to be specifically inactivated in nearly all cases of rhabdoid tumors (RT), highly aggressive cancers that strike young children.12,13 Genetically engineered mouse models then revealed a bona fide tumor suppressor role and induced biallelic inactivation of Snf5 was shown to lead the rapid onset of cancer in all mice.14-17 More recently, via cancer genome sequencing studies, mutations in genes that encode SWI/SNF subunits have been broadly linked to cancer.6 Recurrent, typically inactivating, mutations in at least eight SWI/SNF subunit genes have been identified across a wide spectrum of human cancers. These include mutations in ARID1A (BAF240A), SMARCA4 (BRG1), ARID1B (BAF250B), ARID2 (BAF200), PBRM1 (BAF180), and other SWI/SNF subunit genes. In total, SWI/SNF subunit genes are mutated in 20% of all human cancers, a high rate comparable to that of TP53 (27%).18

The mechanism by which the SWI/SNF complex serves as a tumor suppressor has become an active area of interest. Both in yeast and mammals, the complex has been implicated in DNA repair processes including double-strand break repair, non-homologous end-joining, nucleotide excision repair and DNA decatenation.19-21 This raises the possibility that mutation of the complex gives rise to cancer via disruption of DNA repair processes leading to genetic damage and/or genomic instability. However, an epigenetic mechanism underlying the tumor suppressor role has also been proposed. Interestingly, sequencing analysis of 35 human SNF5-mutant RT samples recently revealed that the genomes of these aggressive SWI/SNF-mutant cancers are remarkably simple: the average exome contained less than five mutations, SNF5 was the sole identified locus that contained repeated mutations, and in two cases was the only mutant gene identified.22 This finding suggests that chromosomal instability is dispensable for the genesis of at least some SWI/SNF mutant cancers. Given that the SWI/SNF complex is capable of modulating chromatin structure, and that epigenetic aberration is now recognized as a hallmark of human cancers,23 these observations have led to speculation that the SWI/SNF complex may suppress tumor formation more by epigenetic transcriptional regulation than by modulation of DNA repair.24,25

The SWI/SNF Complex Regulates Promoter Nucleosomes

In order to investigate the contributions of the SWI/SNF complex to chromatin structure and transcriptional regulation in vivo, we utilized murine embryonic fibroblasts (MEFs) conditional for one of two core SWI/SNF subunits, both tumor suppressors, Snf5 (Smarcb1) and Brg1 (Smarca4).26 This enabled us to genetically inactivate these subunits in normal cells and compare the effects to wild type MEFs. We then performed genome-wide mapping of nucleosomes in these engineered cells with the Mnase-Seq technology. As others and we have found that the SWI/SNF complex is highly enriched at promoters, we analyzed the effects of subunit inactivation upon nucleosomes surrounding transcription start sites (TSS) genome wide. We found that Snf5 and Brg1 are essential for establishment or maintenance of the canonical nucleosome structures flanking TSS. Following acute inactivation of Snf5 or Brg1, nucleosome occupancy in the peri-TSS region including both the -1 and +1 nucleosomes, as well as the +2 to +5 nucleosomes were markedly reduced. In addition, the relative infrequency of nucleosomes at the NDR was further reduced. Overall, the effect of nucleosome loss was broad and at least some reduction could be detected 2kb up- and down-stream the NDR. In addition, phasing of the +2 nucleosome and those further downstream was affected such that each successive nucleosome was shifted an average of 8 bp toward the TSS. Notably, despite the great reduction of nucleosome occupancy, the positions of the -1, +1 nucleosomes, when present, remained identical to the position in wildtype (WT) cells suggesting that Snf5 and Brg1 were not involved in positioning these nucleosomes.

Regulation of the +1 Nucleosome

The +1 nucleosome is unique in that it is the most tightly positioned nucleosome, and is highly modified, and incorporated with histone variants.2 Functionally, the +1 nucleosome is believed to be a gateway for transcription: for example, it is implicated in the regulation of Pol II promoter-proximal pausing and the recruitment of chromatin remodelers/transcription factors to gene promoters. The position of the +1 nucleosome may also influence the positions of the nucleosomes downstream. Perhaps consistent with these special roles, the occupancy and positioning of the +1 nucleosome always seem to be the last to be affected by mutations that disrupts nucleosome assembly in gene bodies.27-29 The effects on the +1 nucleosome are also dramatically lower as compared with the other nucleosomes.27,28 But in our results, SWI/SNF perturbation caused a severe loss of the +1 nucleosome density and this was consistently observed in both the Snf5 and Brg1 deficient MEFs. The extent of nucleosome loss at the +1 position was also similar to that of the other positions. More strikingly, when we analyzed sequencing data derived from human CD36+ erythrocyte precursor cells where BRG1 was knocked down, we made a nearly identical observation.26,30 These findings collectively argue that the SWI/SNF complex is involved in establishing +1 nucleosome density in mammalian cells.

The Contributions of the SWI/SNF Complex to Promoter Nucleosome Positioning

The yeast SWI/SNF complex binds the +1 nucleosome and pulls it away from the NDR.31 In MEFs, consistent with findings in other mammalian cell types, we found that the SWI/SNF complex was substantially enriched at the +1 nucleosomes as indicated by our Brg1 ChIP-Seq data.32 But unlike in yeast, Snf5 or Brg1 loss did not affect the positioning of the residual +1 nucleosomes in MEFs. This result raises the possibility that the mammalian SWI/SNF complex functions distinctly from its yeast counterpart in that we found no effect upon positioning of the +1 nucleosome. However, in order to directly evaluate this, it would be necessary to confirm that the +1 nucleosomes retained in the Snf5 or Brg1 deficient MEFs represented those at SWI/SNF target genes and not just nucleosomes from non-bound genes. Owing to our limited sequencing depth achieved when sequencing nucleosomes genome-wide, we were unable to perform this analysis and thus evaluation of this possibility will rely on future experiments. It is important to note that DNA associated with unstable remodeled nucleosomes, and in certain cases histone variants, can be more sensitive to Mnase digestion, and can result in regions containing such nucleosomes appearing to have no or low nucleosome occupancy during Mnase-Seq analysis.33,34 In this regard, our study cannot rule out the possibility that loss of Snf5 or Brg1 results in unstable nucleosomes, rather than complete nucleosome loss, at promoters. In addition, we did not evaluate placement of variant histones, which can also have effects upon MNase sensitivity, and thus may be an interesting area of future study.

The Effects of SWI/SNF-Mediated Nucleosome Regulation on Gene Transcription

In addition to the effects of SWI/SNF subunit mutation on promoter nucleosomes placement, we also examined how these changes correlated with changes in transcription.26 Surprisingly, gene expression in Snf5 or Brg1 deficient MEFs was only mildly affected in the face of substantial changes in chromatin structure. Most genes in the deficient cells had an expression level fairly similar to that in the control cells. For genes whose expression was altered, the correlation between changes in RNA levels and nucleosome occupancy was moderate. We note that some similar observations have been made in yeast and mammalian cells where mutations that alter gross nucleosome organization did not affect global gene expression.28,35-37 Collectively, these findings are perhaps surprising given prior findings that nucleosomes pose a barrier for transcription.5,38 We speculate that several possible reasons may contribute to this phenomenon. First, nucleosome depletion in promoters is not strictly sufficient for transcription activation. For example, genes with a very low levels of transcription frequency e.g., with less than 1% of the maximum level can still have a well-configured NDR.2 Second, the loss of the nucleosomes especially the +1 nucleosome may represent the loss of modified histones, which serve important roles in marking transcriptional start sites and in recruiting transcriptional regulators to the promoter-proximal region. In this case, effects of removal of the +1 nucleosome barrier may be counterbalanced by impairment in recruitment of transcriptional activators and the transcription machinery. Third, the SWI/SNF complex may exert its effects on gene regulation by modulating gene enhancers, which are functionally as important as the promoters.39 For example, in embryonic stem cells, Brg1 binds to approximately 4% of the genome with its majority binding localized to distal regions that contain gene enhancers.32 Moreover, Brg1 binding correlates more with H3K4me1 than with H3K4me3, further indicating its enrichment at enhancers.32,40 Consequently, further analysis of the chromatin states at enhancers and their correlation with gene expression may provide additional insight in this regard.

Additional explanations are possible for the modest transcriptional changes identified. For example, optimal nucleosome occupancy and positioning conferred by chromatin remodelers have been shown to prohibit cryptic initiation and antisense transcription.29,41,42 Elevated cryptic initiation may lead to accumulation of dominant derivatives that can be detrimental to the cells, especially in the case of malignant transformation.43 In addition, the SWI/SNF ATPase subunit, BRM, has been shown to exert regulation on alternative splicing, which is again essential for normal cell function and impairment of splicing has been implicated in cancer development.44,45 Lastly, nucleosome occupancy in promoters controls transcriptional noise and plasticity.46,47 Here, transcriptional noise refers to the random fluctuation in the expression of a single gene allele in a cell population that is grown under a constant condition. Transcriptional plasticity on the other hand refers to gene expression changes of the same gene under different conditions such as environmental stress, mutations, or developmental transitions. As we evaluated cells in a uniform condition, our experiments would not detect such changes, although Hu and colleagues performed such an evaluation and identified changes in transcription factor binding at enhancers upon BRG1 mutation.30 Collectively, while our experiments implicate the SWI/SNF complex in establishment of nucleosome occupancy, much remains to be determined in how this chromatin remodeling and tumor suppressor complex regulates transcription.

Possible Links between SWI/SNF-Mediated Regulation on Promoter Nucleosomes and the Development of SWI/SNF Mutant Cancers

The disruption of the SWI/SNF complex by mutations is closely related to tumor formation. How would the regulation on promoter nucleosomes by the SWI/SNF complex fit into this process? Recent discoveries have indicated that mutations affecting epigenetic regulators may lead to a state called epigenome instability, under which, cells would have more plasticity toward developing phenotypic heterogeneity.24,48 It is with this heterogeneity that cells could be selected for growth advantage and many other hallmarks of cancers, and then become tumorigenic.48 We thus postulate that the loss of nucleosome occupancy in gene promoters may promote epigenetic instability through mechanisms such as increased cryptic initiation, antisense transcription, aberrant RNA splicing, and abnormal transcriptional noise and plasticity. In this model, the mammalian SWI/SNF complex resides in gene promoters and enhancers and modulates the deposition of nucleosomes. This regulation may facilitate transcriptional fidelity and protect the cells from undergoing epigenetic instability that can select for malignant transformation. Further evaluation of these ideas will have the potential to provide insights into the role of epigenetic dysregulation in oncogenesis.

Disclosure of Potential Conflicts of Interest

No potential conflict of interest was disclosed.

Acknowledgments

This work and our efforts described herein were supported in part by R01CA113794 and R01CA172152 (to CWMR); and Alex’s Lemonade Stand Innovation and Hyundai Hope on Wheels Awards (CWMR). The Garrett B. Smith Foundation, Miles for Mary, Cure AT/RT Now, and the Avalanna Fund (CWMR) provided additional support.

Tolstorukov MY, Sansam CG, Lu P, Koellhoffer EC, Helming KC, Alver BH, Tillman EJ, Evans JA, Wilson BG, Park PJ, Roberts CW. Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters. Proc Natl Acad Sci U S A. 2013;110:10165–70. doi: 10.1073/pnas.1302209110.

10.4161/nucl.26654

Footnotes

References

  • 1.Woodcock CL, Ghosh RP. Chromatin higher-order structure and dynamics. Cold Spring Harb Perspect Biol. 2010;2:a000596. doi: 10.1101/cshperspect.a000596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Jiang C, Pugh BF. Nucleosome positioning and gene regulation: advances through genomics. Nat Rev Genet. 2009;10:161–72. doi: 10.1038/nrg2522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Struhl K, Segal E. Determinants of nucleosome positioning. Nat Struct Mol Biol. 2013;20:267–73. doi: 10.1038/nsmb.2506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zhang Z, Wippo CJ, Wal M, Ward E, Korber P, Pugh BF. A packing mechanism for nucleosome organization reconstituted across a eukaryotic genome. Science. 2011;332:977–80. doi: 10.1126/science.1200508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cairns BR. The logic of chromatin architecture and remodelling at promoters. Nature. 2009;461:193–8. doi: 10.1038/nature08450. [DOI] [PubMed] [Google Scholar]
  • 6.Wilson BG, Roberts CW. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer. 2011;11:481–92. doi: 10.1038/nrc3068. [DOI] [PubMed] [Google Scholar]
  • 7.Whitehouse I, Flaus A, Cairns BR, White MF, Workman JL, Owen-Hughes T. Nucleosome mobilization catalysed by the yeast SWI/SNF complex. Nature. 1999;400:784–7. doi: 10.1038/23506. [DOI] [PubMed] [Google Scholar]
  • 8.Kassabov SR, Zhang B, Persinger J, Bartholomew B. SWI/SNF unwraps, slides, and rewraps the nucleosome. Mol Cell. 2003;11:391–403. doi: 10.1016/S1097-2765(03)00039-X. [DOI] [PubMed] [Google Scholar]
  • 9.Phelan ML, Schnitzler GR, Kingston RE. Octamer transfer and creation of stably remodeled nucleosomes by human SWI-SNF and its isolated ATPases. Mol Cell Biol. 2000;20:6380–9. doi: 10.1128/MCB.20.17.6380-6389.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Reisman D, Glaros S, Thompson EA. The SWI/SNF complex and cancer. Oncogene. 2009;28:1653–68. doi: 10.1038/onc.2009.4. [DOI] [PubMed] [Google Scholar]
  • 11.Ho L, Crabtree GR. Chromatin remodelling during development. Nature. 2010;463:474–84. doi: 10.1038/nature08911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Versteege I, Sévenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 1998;394:203–6. doi: 10.1038/28212. [DOI] [PubMed] [Google Scholar]
  • 13.Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 1999;59:74–9. [PubMed] [Google Scholar]
  • 14.Roberts CW, Leroux MM, Fleming MD, Orkin SH. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell. 2002;2:415–25. doi: 10.1016/S1535-6108(02)00185-X. [DOI] [PubMed] [Google Scholar]
  • 15.Roberts CW, Galusha SA, McMenamin ME, Fletcher CD, Orkin SH. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc Natl Acad Sci U S A. 2000;97:13796–800. doi: 10.1073/pnas.250492697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Guidi CJ, Sands AT, Zambrowicz BP, Turner TK, Demers DA, Webster W, Smith TW, Imbalzano AN, Jones SN. Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol Cell Biol. 2001;21:3598–603. doi: 10.1128/MCB.21.10.3598-3603.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Klochendler-Yeivin A, Fiette L, Barra J, Muchardt C, Babinet C, Yaniv M. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep. 2000;1:500–6. doi: 10.1093/embo-reports/kvd129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, Crabtree GR. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet. 2013;45:592–601. doi: 10.1038/ng.2628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Dykhuizen EC, Hargreaves DC, Miller EL, Cui K, Korshunov A, Kool M, Pfister S, Cho YJ, Zhao K, Crabtree GR. BAF complexes facilitate decatenation of DNA by topoisomerase IIα. Nature. 2013;497:624–7. doi: 10.1038/nature12146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Park JH, Park EJ, Lee HS, Kim SJ, Hur SK, Imbalzano AN, Kwon J. Mammalian SWI/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction. EMBO J. 2006;25:3986–97. doi: 10.1038/sj.emboj.7601291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zhao Q, Wang QE, Ray A, Wani G, Han C, Milum K, Wani AA. Modulation of nucleotide excision repair by mammalian SWI/SNF chromatin-remodeling complex. J Biol Chem. 2009;284:30424–32. doi: 10.1074/jbc.M109.044982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lee RS, Stewart C, Carter SL, Ambrogio L, Cibulskis K, Sougnez C, Lawrence MS, Auclair D, Mora J, Golub TR, et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J Clin Invest. 2012;122:2983–8. doi: 10.1172/JCI64400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2010;31:27–36. doi: 10.1093/carcin/bgp220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.McKenna ES, Roberts CW. Epigenetics and cancer without genomic instability. Cell Cycle. 2009;8:23–6. doi: 10.4161/cc.8.1.7290. [DOI] [PubMed] [Google Scholar]
  • 25.Lee RS, Roberts CW. Rhabdoid tumors: an initial clue to the role of chromatin remodeling in cancer. Brain Pathol. 2013;23:200–5. doi: 10.1111/bpa.12021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Tolstorukov MY, Sansam CG, Lu P, Koellhoffer EC, Helming KC, Alver BH, Tillman EJ, Evans JA, Wilson BG, Park PJ, et al. Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters. Proc Natl Acad Sci U S A. 2013;110:10165–70. doi: 10.1073/pnas.1302209110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Batta K, Zhang Z, Yen K, Goffman DB, Pugh BF. Genome-wide function of H2B ubiquitylation in promoter and genic regions. Genes Dev. 2011;25:2254–65. doi: 10.1101/gad.177238.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Gkikopoulos T, Schofield P, Singh V, Pinskaya M, Mellor J, Smolle M, Workman JL, Barton GJ, Owen-Hughes T. A role for Snf2-related nucleosome-spacing enzymes in genome-wide nucleosome organization. Science. 2011;333:1758–60. doi: 10.1126/science.1206097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Pointner J, Persson J, Prasad P, Norman-Axelsson U, Strålfors A, Khorosjutina O, Krietenstein N, Svensson JP, Ekwall K, Korber P. CHD1 remodelers regulate nucleosome spacing in vitro and align nucleosomal arrays over gene coding regions in S. pombe. EMBO J. 2012;31:4388–403. doi: 10.1038/emboj.2012.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hu G, Schones DE, Cui K, Ybarra R, Northrup D, Tang Q, Gattinoni L, Restifo NP, Huang S, Zhao K. Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1. Genome Res. 2011;21:1650–8. doi: 10.1101/gr.121145.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Yen K, Vinayachandran V, Batta K, Koerber RT, Pugh BF. Genome-wide nucleosome specificity and directionality of chromatin remodelers. Cell. 2012;149:1461–73. doi: 10.1016/j.cell.2012.04.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ho L, Jothi R, Ronan JL, Cui K, Zhao K, Crabtree GR. An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc Natl Acad Sci U S A. 2009;106:5187–91. doi: 10.1073/pnas.0812888106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Jin C, Zang C, Wei G, Cui K, Peng W, Zhao K, Felsenfeld G. H3.3/H2A.Z double variant-containing nucleosomes mark ‘nucleosome-free regions’ of active promoters and other regulatory regions. Nat Genet. 2009;41:941–5. doi: 10.1038/ng.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Weiner A, Hughes A, Yassour M, Rando OJ, Friedman N. High-resolution nucleosome mapping reveals transcription-dependent promoter packaging. Genome Res. 2010;20:90–100. doi: 10.1101/gr.098509.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Wyrick JJ, Holstege FC, Jennings EG, Causton HC, Shore D, Grunstein M, Lander ES, Young RA. Chromosomal landscape of nucleosome-dependent gene expression and silencing in yeast. Nature. 1999;402:418–21. doi: 10.1038/46567. [DOI] [PubMed] [Google Scholar]
  • 36.Celona B, Weiner A, Di Felice F, Mancuso FM, Cesarini E, Rossi RL, Gregory L, Baban D, Rossetti G, Grianti P, et al. Substantial histone reduction modulates genomewide nucleosomal occupancy and global transcriptional output. PLoS Biol. 2011;9:e1001086. doi: 10.1371/journal.pbio.1001086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Teif VB, Vainshtein Y, Caudron-Herger M, Mallm JP, Marth C, Höfer T, Rippe K. Genome-wide nucleosome positioning during embryonic stem cell development. Nat Struct Mol Biol. 2012;19:1185–92. doi: 10.1038/nsmb.2419. [DOI] [PubMed] [Google Scholar]
  • 38.Petesch SJ, Lis JT. Overcoming the nucleosome barrier during transcript elongation. Trends Genet. 2012;28:285–94. doi: 10.1016/j.tig.2012.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Lenhard B, Sandelin A, Carninci P. Metazoan promoters: emerging characteristics and insights into transcriptional regulation. Nat Rev Genet. 2012;13:233–45. doi: 10.1038/nrg3163. [DOI] [PubMed] [Google Scholar]
  • 40.Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet. 2007;39:311–8. doi: 10.1038/ng1966. [DOI] [PubMed] [Google Scholar]
  • 41.Whitehouse I, Rando OJ, Delrow J, Tsukiyama T. Chromatin remodelling at promoters suppresses antisense transcription. Nature. 2007;450:1031–5. doi: 10.1038/nature06391. [DOI] [PubMed] [Google Scholar]
  • 42.Kaplan CD, Laprade L, Winston F. Transcription elongation factors repress transcription initiation from cryptic sites. Science. 2003;301:1096–9. doi: 10.1126/science.1087374. [DOI] [PubMed] [Google Scholar]
  • 43.Guidos C. “Cryptic” Notch1 messages induce T-ALL. Blood. 2010;116:5436–8. doi: 10.1182/blood-2010-10-311712. [DOI] [PubMed] [Google Scholar]
  • 44.Batsché E, Yaniv M, Muchardt C. The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nat Struct Mol Biol. 2006;13:22–9. doi: 10.1038/nsmb1030. [DOI] [PubMed] [Google Scholar]
  • 45.David CJ, Manley JL. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev. 2010;24:2343–64. doi: 10.1101/gad.1973010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Tirosh I, Barkai N. Two strategies for gene regulation by promoter nucleosomes. Genome Res. 2008;18:1084–91. doi: 10.1101/gr.076059.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Raser JM, O’Shea EK. Control of stochasticity in eukaryotic gene expression. Science. 2004;304:1811–4. doi: 10.1126/science.1098641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Timp W, Feinberg AP. Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat Rev Cancer. 2013;13:497–510. doi: 10.1038/nrc3486. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nucleus are provided here courtesy of Taylor & Francis

RESOURCES